Medical Cannabis Studies

• View All (505)

Cannabinoids and Neuroprotection in Basal Ganglia Disorders (2007)

A promising hope lies in the therapeutic potential of cannabinoids as neuroprotective against neurodegenerative disorders such as chronic Parkinson’s or Huntington’s diseases. View study
Cannabinoids and omega-3/6 endocannabinoids as cell death and anticancer modulators (2013)

Currently cannabinoids are used only in cancer treatment for nausea associated with chemotherapy and radiotherapy and pain associated with cancer. There have also been trials on brain tumors in patients, but more studies are needed to determine the real potential of these compounds in cancer therapy. View study
Cannabinoids and the gastrointestinal tract (2001)

This research focuses on the study Cannabinoids and the gastrointestinal tract. The tests conducted in this study suggest further research to investigate the role of both endogenous cannabinoid receptor agonists and non-CB1 cannabinoid receptors in the gastrointestinal tract. View study
Cannabinoids and the immune system (2001)

This research was based on the study of cannabinoids and the immune system. It could be concluded that these drugs have subtle but complex effects on the function of immune cells and that part of the activity of the drugs is mediated by the cannabinoid receptors expressed in the various subtypes of immune cells. View study
Cannabinoids as novel anti-inflammatory drugs (2009)

This study focused on the potential use of cannabinoids as a new instrument to treat inflammatory and autoimmune diseases that are usually activated by activated T cells or other cellular immune elements. View study
Cannabinoids as therapeutic agents in cancer: current status and future implications (2014)

Cannabinoids derived from different sources can regulate different signaling pathways, modulate different types of tumor cells and the physiological system of the host. View study
Cannabinoids control spasticity and tremor in a multiple sclerosis model (2000)

Cannabis has great therapeutic potential for the control of the symptoms of multiple sclerosis. View study
Cannabinoids for Cancer Treatment: Progress and Promise (2008)

Studies conducted on cannabinoids have reported that these can be useful adjuvants for conventional chemotherapeutic regimens, preventing nausea, vomiting, reducing pain and stimulating appetite. Cannabinoids are proving to be unique in terms of their specific action on cancer cells and their ability to preserve normal cells. However, more studies and tests are needed to determine with complete certainty if cannabinoids could be used to inhibit the growth of tumors in a clinical setting. View study
Cannabinoids for fibromyalgia (2016)

Fibromyalgia is a clinically well defined chronic condition of unknown etiology characterized by chronic widespread pain that often coexists with sleep and fatigue problems that affect approximately 2% of the general population. The present review focused on evaluating the efficacy, tolerability and safety of cannabinoids for the symptoms of fibromyalgia in adults. It could be concluded that no convincing, impartial and high quality evidence was found to suggest that nabilone is valuable in the treatment of people with fibromyalgia. The tolerability of nabilone was low in people with fibromyalgia. View study
Cannabinoids for pediatric epilepsy? Up in smoke or real science? (2015)

Trials and controlled studies on the effects of cannabidiol in children with epilepsy have shown high quality medical evidence regarding its therapeutic benefits. View study
Cannabinoids for the treatment of dementia (2009)

Cannabinoids may have more positive and specific effects on the disruption of the disease process in Alzheimer’s disease. View study
Cannabinoids for treatment of Alzheimer�s disease: moving toward the clinic (2014)

The cannabinoid compounds have polyvalent properties for the treatment of Alzheimer’s disease, which together promote progress towards a clinical trial. View study